Results with the Roseland(®) HAC trapeziometacarpal prosthesis after more than 10 years.

Chir Main

Service de chirurgie de la main et des brûlés, hôpital Michallon, CHU de Grenoble, boulevard de la Chantourne, BP217, 38043 Grenoble cedex 09, France.

Published: April 2015

The Roseland(®) hydroxyapatite-coated prosthesis is a total trapeziometacarpal joint prosthesis used for the surgical treatment of thumb basal joint arthritis. The aim of this retrospective study was to evaluate its long-term outcomes. Fifty-one patients (64 thumbs) underwent trapeziometacarpal joint replacement with this prosthesis. The mean follow-up was 12.5 years. Survival rate of the prosthesis was 91%. There was either no pain or only occasional pain in 91% of cases. The mean QuickDASH score was 27.6. Abnormal radiographic findings were present in 70% of cases. Since they were often asymptomatic, no further treatment was carried out. Complications were common (25%) and occurred early on but could often be treated without surgery. The long-term results with the Roseland(®) HAC prosthesis are satisfactory in terms of pain relief and function. However, the high complication rate is a major concern.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.main.2015.01.004DOI Listing

Publication Analysis

Top Keywords

roseland® hac
8
trapeziometacarpal joint
8
prosthesis
6
hac trapeziometacarpal
4
trapeziometacarpal prosthesis
4
prosthesis years
4
years roseland®
4
roseland® hydroxyapatite-coated
4
hydroxyapatite-coated prosthesis
4
prosthesis total
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!